This episode provides MedTech innovators with a foundational blueprint for embedding a global regulatory strategy into their product development process from the very beginning. We explore why a reactive, market-by-market approach fails and outline the critical early-stage decisions in market selection, quality management, and clinical evidence that pave the way for faster, more efficient international market access. Key Questions: • Why is a 'launch and learn' regulatory approach so risky for new devices? • How can early market selection influence your core product design? • What is the single most important standard to build your global strategy upon? • How do you design a clinical trial to satisfy multiple global regulators simultaneously? • What are the hidden costs of ignoring labeling and translation requirements until the last minute? • How has the EU MDR changed the game for clinical evidence worldwide? • When should you really start budgeting for global regulatory submissions? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.